BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Liver
,
Anticancer prodrugs
,
Doxorubicin
,
rs4950928
,
KLK3
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MRRs
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for MRRs
Explore Curated Studies Results
Literature
Most Relevant Literature
An oligomeric switch controls the Mrr-induced SOS response in E. coli.
XPF-673C>T polymorphism effect on the susceptibility to esophageal cancer in Chinese population.
A comprehensive series of Irx cluster mutants reveals diverse roles in facial cartilage development.
Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) w…
Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increase…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia
Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibito…
Outcomes of Meniscus Root Repair Using a Transtibial Pullout Technique
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenst…
Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Re…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ